Home The Active Ingredient Matrix Terminalia bellirica (Belleric acid)

Formulation Intelligence

Terminalia bellirica (Belleric acid)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Terminalia bellirica (Belleric acid).

Terminalia bellirica functions as a potent xanthine oxidase inhibitor and hepatoprotective agent, primarily utilized for the management of hyperuricemia and oxidative stress-induced hepatic dysfunction.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

119031

Molecular Weight

331.41 g/mol

XLogP3 (Lipophilicity)

0.5

IUPAC Name

(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Terminalia chebula for synergistic antioxidant network stabilization and digestive motility
  • Phyllanthus emblica for enhanced hepatoprotective effects and vitamin C-mediated redox recycling

Biological Formulation Enhancers

  • Piperine for inhibition of P-glycoprotein-mediated efflux to increase transepithelial transport
  • Quercetin for synergistic inhibition of xanthine oxidase and improved metabolic stability

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Terminalia bellirica (Belleric acid) across standard consumer modalities.

💊 Standard Capsules

The high hygroscopicity of polyphenolic tannins in the extract necessitates moisture-barrier packaging to prevent clumping and degradation within HPMC or gelatin shells.

🍬 Gummy & Pectin Formats

The intense astringency and bitter profile of Belleric acid require complex flavor masking and can interfere with pectin cross-linking, potentially compromising the structural integrity of the gel matrix.

🔬 Thin-Film Oral Strips

The relatively high therapeutic dose required for Belleric acid exceeds the typical 20-30mg payload capacity of thin-film polymers, making it difficult to achieve clinical efficacy in a single strip.

For Brand Founders

Formulate with Terminalia bellirica (Belleric acid)

Ready to launch a product featuring Terminalia bellirica (Belleric acid)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Terminalia bellirica (Belleric acid) Bioavailability

Need absolute proof that your Terminalia bellirica (Belleric acid) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Terminalia bellirica (Belleric acid) Degradation Testing

Is your Terminalia bellirica (Belleric acid) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation